TP53 and Miyoshi myopathy: Likewise, bone marrow derived exosomes educate MM cells in a way that promotes their growth as well as drug resistance to bortezomib, a proteasome inhibitor used in MM treatment, by modulating the activation of survival pathways such as p38, p53 and Akt [94].